Brief: SanBio begins clinical trial of regenerative cell medicine for patients with traumatic brain injury

SanBio

21/09/2016 07:15

Sept 21 (Reuters) - SanBio Co Ltd   4592.T :  
     
       
    * Says it began a Phase 2 clinical trial regenerative cell 
medicine SB623 for patients affected by traumatic brain injury 
in Japan  
     
     
    Source text in Japanese:https://goo.gl/lOYQ9A 
    Further company coverage: 4592.T  
 
 (Beijing Headline News) 
 ((Beijing.HeadlineNews@thomsonreuters.com; +86 10 62674724; 
Reuters Messaging: jun.cao.reuters.com@reuters.net))